The studies demonstrated effective AdV transduction of hepatocytes and increased OTC transgene expression levels in the liver, leading to the correction of the metabolic defect following intravenous vector injection in adult mice with OTCD. This evidence concerns the gene OTC and ornithine carbamoyltransferase deficiency.